Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02624843 · ClinicalTrials.gov registry record · Phase 3
Bioequivalence Study for Benzyl Alcohol Lotion 5%.
A Phase 3 study, sponsored by Akorn.
- Completed
- Registry status
- Phase 3
- Development phase
- 239
- Enrollment target
NCT02624843 is a Phase 3 study that has completed, run by Akorn. The registered enrollment target is 239 participants.
The verdict
NCT02624843, a Phase 3 study, has completed, sponsored by Akorn.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 239 participants
- Enrollment target
Study Summary
To establish the therapeutic equivalence and safety of a generic Benzyl Alcohol Lotion 5% with Ulesfia Lotion 5% in eradication of head lice in the study subjects.
Interventions
- DRUG Placebo
- DRUG Benzyl Alcohol Lotion 5%
- DRUG Ulesfia (benzyl alcohol lotion) 5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2015-08 |
| Est. Completion | 2015-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02624843
The ClinicalTrials.gov registry entry for NCT02624843 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akorn, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02624843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02624843 about?
NCT02624843 is a clinical study titled "Bioequivalence Study for Benzyl Alcohol Lotion 5%.". To establish the therapeutic equivalence and safety of a generic Benzyl Alcohol Lotion 5% with Ulesfia Lotion 5% in eradication of head lice in the study subjects.
What is the current status of trial NCT02624843?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 239 participants. The study started on 2015-08. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02624843?
The interventions under investigation include: Placebo (DRUG), Benzyl Alcohol Lotion 5% (DRUG), Ulesfia (benzyl alcohol lotion) 5% (DRUG).
Who is sponsoring clinical trial NCT02624843?
This trial is sponsored by Akorn, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.